Clover Health Investments' (CLOV) CEO Vivek Garipalli on Q4 2020 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q4: 2021-03-01 Earnings Summary

EPS of -$2.95 misses by $2.49
 | Revenue of $166.23M misses by $724.67K

Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2020 Earnings Conference Call March 1, 2021 5:00 PM ET

Company Participants

Vivek Garipalli – Chief Executive Officer
Andrew Toy – President and Chief Technology Officer
Joe Wagner – Chief Financial Officer

Conference Call Participants

Kevin Fischbeck – Bank of America
Gary Taylor – JPMorgan
Ralph Giacobbe – Citi

Operator

Ladies and gentlemen, thank you for standing by and welcome to the Clover Health Fourth Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today’s program may be recorded.

And now I’d like to introduce your host for today’s program, Dylan Solomon [ph], please go ahead.

Unidentified Company Representative

Welcome to Clover Health’s inaugural earnings call, where we will discuss Clover Health’s fourth quarter and full year 2020 results, our 2021 financial outlook and a comprehensive update on the business. Joining me today are Vivek Garipalli, Chief Executive Officer; Andrew Toy, President and CTO; and Joe Wagner, Chief Financial Officer.

Before turning the call over to Vivek, I’d like to let you know that today’s call is being broadcast to Clover Health’s Investor Relations website. During today’s presentation, we will make forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or future financial or operating performance. Our expectations and beliefs regarding these matters may not materialize and actual results in financial periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include those set forth in the press release we issued earlier today, as well as those more fully described in our filings with the Securities and Exchange Commission.

Forward-looking statements in this presentation are

Recommended For You

About CLOV Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CLOV